BERRINO, ENRICO
BERRINO, ENRICO
SCIENZE MEDICHE
223P Artificial intelligence-based pathomics biomarker predict primary resistance to first-line treatment in metastatic colorectal cancers
2023-01-01 Mauri, G.; Giannini, V.; Nicoletti, G.; Lazzari, L.; Sartore Bianchi, A.; Marmorino, F.; Randon, G.; Nieva Munoz, M.; Saoudi Gonzalez, N.; Puccini, A.; Berrino, E.; Marchiò, C.; Di Como, M.; Aquilano, M.C.; Arena, S.; Torri, V.; Siena, S.; Bardelli, A.; Regge, D.; Marsoni, S.
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells
2018-01-01 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models
2019-01-01 Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero
Identification of Actionable Cancer Genes and Treatment Options for Metastatic Ovarian Carcinomas using Patient Derived Xenografts (PDXs) and PDX Derived Tumor Cells (PDTCs)
2018-01-01 Concetta D’Ambrosio, Martina Olivero, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Enrico Berrino, Tiziana Vanesio, Stefania Bolla, Giorgio Valabrega, Raffaele Calogero and Maria Flavia Di Renzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 223P Artificial intelligence-based pathomics biomarker predict primary resistance to first-line treatment in metastatic colorectal cancers | 2023 | Mauri, G.; Giannini, V.; Nicoletti, G.; Lazzari, L.; Sartore Bianchi, A.; Marmorino, F.; Randon, G.; Nieva Munoz, M.; Saoudi Gonzalez, N.; Puccini, A.; Berrino, E.; Marchiò, C.; Di Como, M.; Aquilano, M.C.; Arena, S.; Torri, V.; Siena, S.; Bardelli, A.; Regge, D.; Marsoni, S. | |
| Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells | 2018 | Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di | |
| Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models | 2019 | Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero | |
| Identification of Actionable Cancer Genes and Treatment Options for Metastatic Ovarian Carcinomas using Patient Derived Xenografts (PDXs) and PDX Derived Tumor Cells (PDTCs) | 2018 | Concetta D’Ambrosio, Martina Olivero, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Enrico Berrino, Tiziana Vanesio, Stefania Bolla, Giorgio Valabrega, Raffaele Calogero and Maria Flavia Di Renzo |